Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

HIV and COPD: a conspiracy of risk factors.

Lalloo UG, Pillay S, Mngqibisa R, Abdool-Gaffar S, Ambaram A.

Respirology. 2016 Oct;21(7):1166-72. doi: 10.1111/resp.12806. Epub 2016 May 30. Review.

2.

Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma.

Mehta N, Aggarwal B, Gogtay J, Abdool-Gaffar S.

Expert Opin Drug Deliv. 2015 Jun;12(6):963-75. doi: 10.1517/17425247.2015.987661. Epub 2014 Nov 27. Review.

PMID:
25429610
3.

South African tobacco smoking cessation clinical practice guideline.

van Zyl-Smit RN, Allwood B, Stickells D, Symons G, Abdool-Gaffar S, Murphy K, Lalloo U, Vanker A, Dheda K, Richards G.

S Afr Med J. 2013 Sep 30;103(11):869-76. doi: 10.7196/samj.7484.

PMID:
24148176
4.

Tiotropium Respimat inhaler and the risk of death in COPD.

Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators.

N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30.

Supplemental Content

Loading ...
Support Center